The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.
 
Maria Toki
No Relationships to Disclose
 
Nikita Mani
No Relationships to Disclose
 
James William Smithy
No Relationships to Disclose
 
Yuting Liu
No Relationships to Disclose
 
Mehmet Altan
No Relationships to Disclose
 
Brad Wasserman
No Relationships to Disclose
 
Rasikh Tuktamyshov
No Relationships to Disclose
 
Konstantinos N. Syrigos
No Relationships to Disclose
 
David L. Rimm
Stock and Other Ownership Interests - Metamark Genetics
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Cell Signaling Technology; Genentech
Consulting or Advisory Role - AstraZeneca; Bethyl Laboratories; Biocept; Bristol-Myers Squibb; Cernostics; Five Prime Therapeutics; Genoptix; Optra SCAN; Perkin Elmer
Research Funding - Cepheid; Gilead Sciences; Kolltan Pharmaceuticals; OncoPlex Diagnostics; Perkin Elmer; Pierre Fabre (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Ventana Medical Systems